My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 97

    1.

    Metabolic dysregulation with atypical antipsychotics occurs in the absence of underlying disease: a placebo-controlled study of olanzapine and risperidone in dogs.

    Ader M, Kim SP, Catalano KJ, Ionut V, Hucking K, Richey JM, Kabir M, Bergman RN.

    Diabetes. 2005 Mar;54(3):862-71.PMID: 15734866 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Ethnic heterogeneity in glucoregulatory function during treatment with atypical antipsychotics in patients with schizophrenia.

    Ader M, Garvey WT, Phillips LS, Nemeroff CB, Gharabawi G, Mahmoud R, Greenspan A, Berry SA, Musselman DL, Morein J, Zhu Y, Mao L, Bergman RN.

    J Psychiatr Res. 2008 Oct;42(13):1076-85. Epub 2008 Feb 25.PMID: 18295798 [PubMed - indexed for MEDLINE]Related articles

    3.

    The effects of atypical antipsychotics on visceral fat distribution in first episode, drug-naive patients with schizophrenia.

    Ryan MC, Flanagan S, Kinsella U, Keeling F, Thakore JH.

    Life Sci. 2004 Mar 5;74(16):1999-2008. Erratum in: Life Sci. 2004 Oct 22;75(23):2851. PMID: 14967195 [PubMed - indexed for MEDLINE]Related articles

    4.

    A comparison of the effects of olanzapine and risperidone versus placebo on ghrelin plasma levels.

    Roerig JL, Steffen KJ, Mitchell JE, Crosby RD, Gosnell BA.

    J Clin Psychopharmacol. 2008 Feb;28(1):21-6.PMID: 18204336 [PubMed - indexed for MEDLINE]Related articles

    5.

    Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review.

    Newcomer JW.

    CNS Drugs. 2005;19 Suppl 1:1-93. Review.PMID: 15998156 [PubMed - indexed for MEDLINE]Related articles

    6.

    The distinct effects of subchronic antipsychotic drug treatment on macronutrient selection, body weight, adiposity, and metabolism in female rats.

    Fell MJ, Anjum N, Dickinson K, Marshall KM, Peltola LM, Vickers S, Cheetham S, Neill JC.

    Psychopharmacology (Berl). 2007 Oct;194(2):221-31. Epub 2007 Jun 21.PMID: 17581744 [PubMed - indexed for MEDLINE]Related articles

    7.

    Atypical antipsychotics and glucose homeostasis.

    Bergman RN, Ader M.

    J Clin Psychiatry. 2005 Apr;66(4):504-14. Review.PMID: 15816794 [PubMed - indexed for MEDLINE]Related articles

    8.

    The discriminative stimulus properties of the atypical antipsychotic olanzapine in rats.

    Porter JH, McCallum SE, Varvel SA, Vann RE.

    Psychopharmacology (Berl). 2000 Feb;148(3):224-33.PMID: 10755735 [PubMed - indexed for MEDLINE]Related articles

    9.

    Investigation into the influence of a high fat diet on antipsychotic-induced weight gain in female rats.

    Fell MJ, Neill JC, Anjum N, Peltola LM, Marshall KM.

    J Psychopharmacol. 2008 Mar;22(2):182-6. Epub 2008 Feb 28.PMID: 18308803 [PubMed - indexed for MEDLINE]Related articles

    10.

    Long-term antipsychotic treatments and crossover studies in rats: differential effects of typical and atypical agents on the expression of antioxidant enzymes and membrane lipid peroxidation in rat brain.

    Pillai A, Parikh V, Terry AV Jr, Mahadik SP.

    J Psychiatr Res. 2007 Aug;41(5):372-86. Epub 2006 Mar 27.PMID: 16564057 [PubMed - indexed for MEDLINE]Related articles

    11.

    A comparison of the effects of olanzapine and risperidone versus placebo on eating behaviors.

    Roerig JL, Mitchell JE, de Zwaan M, Crosby RD, Gosnell BA, Steffen KJ, Wonderlich SA.

    J Clin Psychopharmacol. 2005 Oct;25(5):413-8.PMID: 16160615 [PubMed - indexed for MEDLINE]Related articles

    12.

    Effects of olanzapine in male rats: enhanced adiposity in the absence of hyperphagia, weight gain or metabolic abnormalities.

    Cooper GD, Pickavance LC, Wilding JP, Harrold JA, Halford JC, Goudie AJ.

    J Psychopharmacol. 2007 Jun;21(4):405-13. Epub 2006 Oct 18.PMID: 17050655 [PubMed - indexed for MEDLINE]Related articles

    13.

    Comparative effects of the antipsychotics sulpiride and risperidone in female rats on energy balance, body composition, fat morphology and macronutrient selection.

    Baptista T, de Baptista EA, Lalonde J, Plamondon J, Kin NM, Beaulieu S, Joober R, Richard D.

    Prog Neuropsychopharmacol Biol Psychiatry. 2004 Dec;28(8):1305-11.PMID: 15588757 [PubMed - indexed for MEDLINE]Related articles

    14.

    Metabolic risk with second-generation antipsychotic treatment: a double-blind randomized 8-week trial of risperidone and olanzapine.

    Kelly DL, Conley RR, Love RC, Morrison JA, McMahon RP.

    Ann Clin Psychiatry. 2008 Apr-Jun;20(2):71-8.PMID: 18568578 [PubMed - indexed for MEDLINE]Related articles

    15.

    Longitudinal compensation for fat-induced insulin resistance includes reduced insulin clearance and enhanced beta-cell response.

    Mittelman SD, Van Citters GW, Kim SP, Davis DA, Dea MK, Hamilton-Wessler M, Bergman RN.

    Diabetes. 2000 Dec;49(12):2116-25.PMID: 11118015 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Comparison of olanzapine and risperidone in 367 first-episode patients with non-affective or affective psychosis: results of an open retrospective medical record study.

    Lambert M, Conus P, Schimmelmann BG, Eide P, Ward J, Yuen H, Schacht M, Edwards J, Naber D, McGorry PD.

    Pharmacopsychiatry. 2005 Sep;38(5):206-13.PMID: 16189747 [PubMed - indexed for MEDLINE]Related articles

    17.

    Distinct endocrine effects of chronic haloperidol or risperidone administration in male rats.

    Lin EJ, Lee NJ, Slack K, Karl T, Duffy L, O'brien E, Matsumoto I, Dedova I, Herzog H, Sainsbury A.

    Neuropharmacology. 2006 Dec;51(7-8):1129-36. Epub 2006 Aug 21.PMID: 16919686 [PubMed - indexed for MEDLINE]Related articles

    18.

    Acute effects of atypical antipsychotics on whole-body insulin resistance in rats: implications for adverse metabolic effects.

    Houseknecht KL, Robertson AS, Zavadoski W, Gibbs EM, Johnson DE, Rollema H.

    Neuropsychopharmacology. 2007 Feb;32(2):289-97. Epub 2006 Oct 11.PMID: 17035934 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    The atypical antipsychotics quetiapine, risperidone and ziprasidone do not increase insulin release in vitro.

    Melkersson K, Jansson E.

    Neuro Endocrinol Lett. 2005 Jun;26(3):205-8.PMID: 15990722 [PubMed - indexed for MEDLINE]Related articles

    20.

    Orally disintegrating olanzapine induces less weight gain in adolescents than standard oral tablets.

    Crocq MA, Guillon MS, Bailey PE, Provost D.

    Eur Psychiatry. 2007 Oct;22(7):453-4. Epub 2007 Aug 30.PMID: 17761403 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity